A61K - Preparations for medical, dental, or toilet purposes

More topics under "A61K - Preparations for medical, dental, or toilet purposes" (2,585,043)
A61K 101 - Radioactive non-metals (526)
A61K 103 - Radioactive metals (481)
A61K 125 - Containing or obtained from roots, bulbs, tubers, corms or rhizomes (2,645)
A61K 127 - Containing or obtained from leaves (1,806)
A61K 129 - Containing or obtained from bark (325)
A61K 131 - Containing or obtained from seeds, nuts, fruits or grains (1,932)
A61K 133 - Containing or obtained from flowers or blossoms (665)
A61K 135 - Containing or obtained from stems, stalks, branches, twigs or shoots (756)
A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213)
A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
A61K 36 - Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines (179,316)
A61K 38 - Medicinal preparations containing peptides (316,240)
A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445)
A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
A61K 49 - Preparations for testing in vivo (35,376)
A61K 50 - Electrically conductive preparations for use in therapy or testing in vivo, e.g. conductive adhesives or gels to be used with electrodes for electrocardiography (ecg) or for transcutaneous drug administration (62)
A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
A61K 6 - Preparations for dentistry (18,259)
A61K 8 - Cosmetics or similar toilet preparations (170,551)
A61K 9 - Medicinal preparations characterised by special physical form (299,044)

Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449)
12/2006
12/21/2006	WO2005051303A3 Screening for synergistic compounds
12/21/2006	WO2005037193A3 Compositions of a cyclooxygenase-2 selective inhibitor administered under hypothermic conditions for the treatment of ischemic mediated central nervous system disorders or injury
12/21/2006	WO2005032468A3 Monocyclic and bicyclic lactams as factor xa inhibitors
12/21/2006	WO2005004812A3 Gelled starch compositions and methods of making gelled starch compositions
12/21/2006	WO2004096153A3 Prostate cancer therapeutics and diagnostics based on conformers of prostatic acid phosphatase
12/21/2006	WO2004078143A3 Methods for identification and uses of anti-inflammatory receptors for eicosapentaenoic acid analogs
12/21/2006	WO2004069184A3 Methods for treating, preventing and detecting helicobacter infection
12/21/2006	WO2004041172A3 Interferon antagonists useful for the treatment of interferon related diseases
12/21/2006	US20060287528 Novel crystalline forms of a phosphoric acid salt of a dipeptidyl peptidase-iv inhibitor
12/21/2006	US20060287525 For post-chemotherapy or post-operative surgery nausea and vomitting; sustained release
12/21/2006	US20060287377 Vanilloid receptor 1 (VR 1) antagonists; efficacy; N-(3-Fluoro-4-methoxy-phenyl)-2-(7-nitro-1H-benzimidazol-1-yl)-acetamide,
12/21/2006	US20060287360 Novel compounds
12/21/2006	US20060287336 S-methyl-dihydro-ziprasidone for treatment of psychiatric and ocular disorders
12/21/2006	US20060287261 Modulation of immunostimulatory properties of oligonucleotide-based compounds by utilizing modified immunostimulatory dinucleotides
12/21/2006	US20060287222 Polymerized hemoglobin solutions having reduced amounts of tetramer and method for preparing
12/21/2006	US20060286116 Methods and compositions for treating B cell cancer
12/21/2006	CA2611263A1 Crystalline forms of a pyrrolotriazine compound
12/20/2006	EP1733729A1 Use of dipyridamole in combination with acetylsalicylic acid and an angiotensin ii antagonist for stroke prevention
12/20/2006	CN1882551A Hexahydrodiazepinones as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes
12/20/2006	CN1882548A pH sensitive prodrugs of 2,6-diisopropylphenol
12/20/2006	CN1882347A AKT protein kinase inhibitors
12/20/2006	CN1882339A Amelioration of macular degeneration and other ophthalmic diseases
12/20/2006	CN1882328A Methods and compositions for the treatment of helicobacter pylori-associated diseases using endoperoxide bridge-containing compounds
12/20/2006	CN1882327A Novel phosphorus-containing thyromimetics
12/20/2006	CN1879877A Tumour-specific animal proteins
12/20/2006	CN1879632A Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive
12/20/2006	CN1879623A Methods of preventing breast cancer
12/19/2006	US7151163 Antiviral agents for the treatment, control and prevention of infections by coronaviruses
12/19/2006	US7151116 Apoptolidin analogs and derivatives for inducing apoptosis in transformed cells
12/19/2006	US7151113 Pyrazole-amine compounds useful as kinase inhibitors
12/19/2006	US7151103 A serotonin receptor antagonists for therapeutic treatment
12/19/2006	CA2301872C 8a-azalides as veterinary antimicrobial agents
12/19/2006	CA2297268C Ready-to-use aqueous compound for dyeing keratic fibres comprising the association of a water-soluble solvent and a nonionic or anionic amphiphilic polymer comprising at least onefatty chain
12/14/2006	WO2005007116A3 Artificial antigen presenting cell devices
12/14/2006	WO2004108069A3 Compositions and methods for promoting neuronal outgrowth
12/14/2006	WO2001022972A9 Immunostimulatory nucleic acids
12/14/2006	US20060281821 Retinoid replacements and opsin agonists and methods for the use thereof
12/14/2006	US20060281813 Methods of treating hyperproliferative cell disorders
12/14/2006	US20060281803 Pyrazole modulators of metabotropic glutamate receptors
12/14/2006	US20060281727 (Cycloalkyleneiminocarbonyl)-indanyl- or -tetrahydronaphthyl- methylamines, e.g., {(1S)-1-[(1S)-5-(4-Fluorophenyl)-2,3-dihydro-1H-inden-1-yl]-2-[(3S)-3-fluoropyrrolidin-1-yl]-2-oxoethyl}amine hydrochloride; particularly for treating type 2 diabetes
12/14/2006	US20060281698 a single-stranded antisense oligonucleotide, targeted to nucleic acid encoding lipid-free protein constituents of plasma lipoproteins, used for diagnosis and therapy of cardiovascular disorders, including myocardial infarction and atherosclerosis
12/14/2006	US20060281146 Novel compositions and methods for the treatment of immune related diseases
12/14/2006	US20060280810 Disinfecting teat care compositions
12/14/2006	US20060280805 Rouge free pharmaceutical water for injection (wfi) water system
12/14/2006	US20060280746 (1E)-1-{[(3-amino-4-methoxyphenyl)methyl]sulfinyl}-2-(2,4,6-trimethoxyphenyl)ethene; antiproliferative agents; offers protection from the cytotoxic effects of ionizing radiation and of cytotoxic chemotherapeutic agents
12/14/2006	US20060280743 Immunoglobulin for treatment of alzheimer's diseases
12/14/2006	US20060280725 Compositions and methods of treating and diagnosing hepatoma
12/14/2006	US20060280679 Method of treating autoimmune disease by inducing antigen presentation by tolerance inducing antigen presenting cells
12/13/2006	EP1731148A1 Bis(thio-hydrazide amide) compounds in combination with taxol for treating cancer
12/13/2006	EP1729747A2 Thiol reactive agents as a therapeutic modality
12/13/2006	EP1615670A4 Targets for tumor growth inhibition
12/13/2006	EP1272219B1 New combination of a betablocker and a cholesterol-lowering agent
12/13/2006	EP1143989B1 Exendins for glucagon suppression
12/13/2006	CN1879065A Magnetically targetable particles comprising magnetic components and biocompatible polymers for site-specific delivery of biologically active agents
12/13/2006	CN1878560A Composition for topic use containing an extract of stryphnodendron, its preparation as well as its application
12/13/2006	CN1878559A Desensitization of compliment activation using monocyte/macrophage inhibitory compounds
12/13/2006	CN1878556A Combinations of drugs for the treatment of neoplasms
12/13/2006	CN1878551A 4-phenyl piperdine sulfonyl glycine transporter inhibitors
12/13/2006	CN1878470A Methods of using regenerative cells in the treatment of peripheral vascular disease and related disorders
12/13/2006	CN1876657A Stabilization of macrolides
12/13/2006	CN1876653A Zolpidem hemitartrate
12/13/2006	CN1876652A Zolpidem hemitartrate
12/13/2006	CN1876648A Piperazinylpyrazine compounds as agonists or antagonists of serotonin 5ht-2 receptors
12/13/2006	CN1289128C A pharmaceutical composition for treating headache disease, preparation process and uses thereof
12/13/2006	CN1289055C Cationic direct dye and direct-dyeing polymer composition used for dyeing keratin-fiber
12/12/2006	US7148242 N-formyl hydroxylamine compounds, compositions and methods of use
12/12/2006	US7148239 Method of enhancing cellular production of molecular chaperon, hydroxylamine derivatives useful for enhancing the chaperon production and the preparation thereof
12/12/2006	US7148220 Tyrosine kinase enzyme inhibitors as growth factor receptors and useful as antiproliferation agents
12/12/2006	US7148206 Methods and compositions for treating flaviviruses and pestiviruses
12/12/2006	US7148197 Orally administered small peptides synergize statin activity
12/12/2006	US7148066 Using ammonia to detect leaks in illegal drugs by evaporation and staining
12/12/2006	CA2272366C Compositions containing an antifungal and a cationic agent
12/07/2006	WO2006130401A2 Method and apparatus for providing light to blood
12/07/2006	WO2005055954A3 Pharmaceutical compounding systems and methods
12/07/2006	WO2005055926A3 Amelioration of cataracts, macular degeneration and other ophthalmic diseases
12/07/2006	WO2005046570A3 Human stem cell materials and methods
12/07/2006	WO2004100861A3 Pharmaceutical composition comprising lectin
12/07/2006	WO2004071435A3 Enhanced Bioavailability Using Laser Resonant Homogenization
12/07/2006	US20060276527 Combination therapies for the treatment of cancer
12/07/2006	US20060276516 Inhibitors of kinases and treatment of diseases mediated by cytokines produced by p38
12/07/2006	US20060276514 Tyrosine kinase inhibitors
12/07/2006	US20060276504 N,N-Dibutyl-2-[3-(2,2-dimethylpropanoyl)-6-methoxy-1H-indazol-1-yl]acetamide; potassium channel blocker; eye neuroprotectant; hypotensive agent; glaucoma, intraoccular pressure in the eye
12/07/2006	US20060276502 Pharmaceutical use of 1-azabicyclo[2.2.2]octanes and a method of testing compounds for the ability of activating inactive wt p53.
12/07/2006	US20060276462 Method of treating cognitive decline due to sleep deprivation and stress
12/07/2006	US20060276450 Isoquinoline potassium channel inhibitors
12/07/2006	US20060276431 Methods for treating severe acute respiratory syndrome
12/07/2006	US20060276420 Generating cells for cell replacement therapy
12/07/2006	US20060276390 Combined treatments comprising synthetic peptide copolymers for preventing graft rejection
12/07/2006	US20060276389 Fugetactic proteins, compositions and methods of use
12/07/2006	US20060276385 Anti-inflammatory agents and methods of their use
12/07/2006	US20060276382 Administering a natriuretic hormone peptide (NHP), or a nucleic acid sequence encoding NHP; respiratory system disorders
12/07/2006	US20060275834 Methods and compositions related to joint inflammation diseases
12/07/2006	US20060275769 Methods of treatment and diagnosis of kaposi's sarcoma (ks) and ks related diseases
12/07/2006	US20060275518 Method for treating infectious diseases
12/07/2006	US20060275511 Jucara and acai fruit-based dietary supplements
12/07/2006	US20060275509 Rapidly absorbing lipophilic skin compositions and uses therefor
12/07/2006	US20060275308 Combination of gallium compounds with nonchemotherapeutic anticancer agents in the treatment of neoplasia
12/06/2006	EP1727915A2 Chimeric infectious dna clones, chimeric porcine circoviruses and uses thereof
12/06/2006	EP1727856A1 Use of a plastic composition and a product obtained thereby
12/06/2006	EP1601339A4 Skin peeling composition and method

1 ... 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 ... 295